Combined Prednisone and Mycophenolate Mofetil Treatment for Retroperitoneal Fibrosis

Journal of Urology

Volumn 178, Issue 1, 2007, Pages 140-144

  Scheel Jr , Paul J ^a   Piccini, Jonathan ^c   Rahman, M Hafizur ^b   Lawler, Leo ^d   Jarrett, Thomas ^e  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

^d MATER MISERICORDIAE UNIVERSITY HOSPITAL   (Ireland)

^e GEORGE WASHINGTON UNIVERSITY HOSPITAL   (United States)

Author keywords

mycophenolate mofetil; prednisone; retroperitoneal fibrosis; ureter; ureteral obstruction

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BROMOCRIPTINE; C REACTIVE PROTEIN; CORTICOSTEROID; CREATININE; ERGOTAMINE; HEMOGLOBIN; HYDRALAZINE; METHYLDOPA; METHYSERGIDE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PERGOLIDE; PREDNISONE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DECOMPRESSION; DRUG EFFICACY; ERYTHROCYTE SEDIMENTATION RATE; EXTUBATION; FEMALE; FOLLOW UP; HUMAN; INFLAMMATION; LABORATORY TEST; MALE; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; REMISSION; RETROPERITONEAL FIBROSIS; TREATMENT DURATION; URETER OBSTRUCTION; URETER STENT; URETER STRICTURE;

ADULT; AGED; CONSTRICTION, PATHOLOGIC; DRUG THERAPY, COMBINATION; FEMALE; GLUCOCORTICOIDS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; MYCOPHENOLIC ACID; PREDNISONE; RETROPERITONEAL FIBROSIS; TOMOGRAPHY, X-RAY COMPUTED; URETER;

EID: 34250359893     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2007.03.057     Document Type: Article

References (19)

1. Vaglio A., Salvarani C., and Buzio C. Retroperitoneal fibrosis. Lancet 367 (2006) 241
2. Choi M.J., Eustace J.A., Gimenez L.F., Attta M.G., Scheel P.J., Sothinathan R., et al. Mycophenolate mofetil treatment for primary glomerular diseases. Kidney Int 61 (2002) 1098
3. Grotz W., von Zedtwitz I., Andre M., and Schollmeyer P. Treatment of retroperitoneal fibrosis by mycophenolate mofetil and corticosteroids. Lancet 352 (1998) 1195
4. Vaglio A., Corradi D., Manenti L., Ferretti S., Garini G., and Buzio C. Evidence of autoimmunity in chronic periaortitis: a prospective study. Am J Med 114 (2003) 454-462
5. Parums D.V., Chadwick D.R., and Mitchinson M.J. The localisation of immunoglobulin in chronic periaortitis. Atherosclerosis 61 (1986) 117
6. Parums D.V., Brown D.L., and Mitchinson M.J. Serum antibodies to oxidized low-density lipoprotein and ceroid in chronic periaortitis. Arch Pathol Lab Med 114 (1990) 383
7. Moder K.G. Mycophenolate mofetil: new applications for this immunosuppressant. Ann Allergy Asthma Immunol 90 (2003) 15
8. Gilkeson G.S., and Allen N.B. Retroperitoneal fibrosis. A true connective tissue disease. Rheum Dis Clin North Am 22 (1996) 23
9. Moroni G., Gallelli B., Banfi G., Sandri S., Messa P., and Ponticelli C. Long-term outcome of idiopathic retroperitoneal fibrosis treated with surgical and/or medical approaches. Nephrol Dial Transplant 21 (2006) 2485
10. Marcolongo R., Tavolini I.M., Laveder F., Busa M., Noventa F., Bassi P., et al. Immunosuppressive therapy for idiopathic retroperitoneal fibrosis: a retrospective analysis of 26 cases. Am J Med 116 (2004) 194
11. Warnatz K., Keskin A.G., Uhl M., Scholz C., Katzenwadel A., Vaith P., et al. Immunosuppressive treatment of chronic periaortitis: a retrospective study of 20 patients with chronic periaortitis and a review of the literature. Ann Rheum Dis 64 (2005) 828
12. van Bommel E.F., Hendriksz T.R., Huiskes A.W., and Zeegers A.G. Brief communication: tamoxifen therapy for nonmalignant retroperitoneal fibrosis. Ann Intern Med 144 (2006) 101
13. Baker L.R., Mallinson W.J., Gregory M.C., Menzies E., Cattell W., Whitefield H., et al. Idiopathic retroperitoneal fibrosis. A retrospective analysis of 60 cases. Br J Urol 60 (1987) 497
14. Wu J., Catalano E., and Coppola D. Retroperitoneal fibrosis (Ormond's disease): clinical pathologic study of eight cases. Cancer Control 9 (2002) 432
15. Kardar A.H., Kattan S., Lindstedt E., and Hanash K. Steroid therapy for idiopathic retroperitoneal fibrosis: dose and duration. J Urol 168 (2002) 550
16. Saag K.G., Koehnke R., Caldwell J.R., Brasington R., Burmeister L.F., Zimmerman B., et al. Low dose long-term corticosteroid therapy in rheumatoid arthritis: an analysis of serious adverse events. Am J Med 96 (1994) 115
17. Kramer S., Loof T., Martini S., Sebastian M., Matthias R., Yingrui W., et al. Mycophenolate mofetil slows progression in anti-thy1-induced chronic renal fibrosis but is not additive to a high dose of enalapril. Am J Physiol Renal Physiol 289 (2005) F359
18. Goncalves R.G., Biato M.A., Colosimo R.D., Martinusso C.A., Pecly I., Farias E., et al. Effects of mycophenolate mofetil and lisinopril on collagen deposition in unilateral ureteral obstruction in rats. Am J Nephrol 24 (2004) 527
19. Morath C., and Zeier M. Review of the antiproliferative properties of mycophenolate mofetil in non-immune cells. Int J Clin Pharmacol Ther 41 (2003) 465